Trial Outcomes & Findings for Postpartum Hypertension: Remote Patient Monitoring (NCT NCT03111095)

NCT ID: NCT03111095

Last Updated: 2025-08-22

Results Overview

A goal of 55 participants enrolled into the mobile health program was set as a feasibility target.

Recruitment status

COMPLETED

Study phase

Target enrollment

428 participants

Primary outcome timeframe

up to 3 months

Results posted on

2025-08-22

Participant Flow

Between March 2017 and July 2017, 55 women were enrolled into a feasibility study for the intervention (Aim 1). Through June 2018, a total of 428 women were enrolled in this study (214 in the intervention group including those from Aim 1 and 214 in the control group). Participants were recruited from Meriter Hospital in Madison, WI.

Participant milestones

Participant milestones
Measure	Mobile Health Participants Participants used the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum. Participants will have a video telehealth visit with the mobile health nurse at 48 hours and 7 days after discharge from the hospital.	Standard of Care This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aim 1: Feasibility and Satisfaction STARTED	55	0
Aim 1: Feasibility and Satisfaction Eligible Participants	263	0
Aim 1: Feasibility and Satisfaction Participants Agreed to be Approached for Study	124	0
Aim 1: Feasibility and Satisfaction Consented to Study	55	0
Aim 1: Feasibility and Satisfaction COMPLETED	52	0
Aim 1: Feasibility and Satisfaction NOT COMPLETED	3	0
Aims 2-5: Intervention STARTED	214	214
Aims 2-5: Intervention Number Analyzed	214	214
Aims 2-5: Intervention COMPLETED	195	214
Aims 2-5: Intervention NOT COMPLETED	19	0

Reasons for withdrawal

Reasons for withdrawal
Measure	Mobile Health Participants Participants used the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum. Participants will have a video telehealth visit with the mobile health nurse at 48 hours and 7 days after discharge from the hospital.	Standard of Care This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aim 1: Feasibility and Satisfaction Withdrawal by Subject	3	0
Aims 2-5: Intervention Withdrawal by Subject	19	0

Baseline Characteristics

Postpartum Hypertension: Remote Patient Monitoring

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum. Participants will have a video telehealth visit with the mobile health nurse at 48 hours and 7 days after discharge from the hospital.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.	Total n=428 Participants Total of all reporting groups
Age, Continuous	31.4 years STANDARD_DEVIATION 5.0 • n=5 Participants	31.5 years STANDARD_DEVIATION 5.5 • n=7 Participants	31.5 years STANDARD_DEVIATION 6.5 • n=5 Participants
Sex: Female, Male Female	214 Participants n=5 Participants	214 Participants n=7 Participants	428 Participants n=5 Participants
Sex: Female, Male Male	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Ethnicity (NIH/OMB) Hispanic or Latino	12 Participants n=5 Participants	15 Participants n=7 Participants	27 Participants n=5 Participants
Ethnicity (NIH/OMB) Not Hispanic or Latino	202 Participants n=5 Participants	199 Participants n=7 Participants	401 Participants n=5 Participants
Ethnicity (NIH/OMB) Unknown or Not Reported	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Race (NIH/OMB) American Indian or Alaska Native	3 Participants n=5 Participants	0 Participants n=7 Participants	3 Participants n=5 Participants
Race (NIH/OMB) Asian	10 Participants n=5 Participants	12 Participants n=7 Participants	22 Participants n=5 Participants
Race (NIH/OMB) Native Hawaiian or Other Pacific Islander	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Race (NIH/OMB) Black or African American	16 Participants n=5 Participants	25 Participants n=7 Participants	41 Participants n=5 Participants
Race (NIH/OMB) White	175 Participants n=5 Participants	168 Participants n=7 Participants	343 Participants n=5 Participants
Race (NIH/OMB) More than one race	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Race (NIH/OMB) Unknown or Not Reported	10 Participants n=5 Participants	9 Participants n=7 Participants	19 Participants n=5 Participants
Region of Enrollment United States	214 participants n=5 Participants	214 participants n=7 Participants	428 participants n=5 Participants
Pre-pregnancy BMI	31.8 kg/m^2 n=5 Participants	30.6 kg/m^2 n=7 Participants	31.2 kg/m^2 n=5 Participants
Delivery BMI	37.4 kg/m^2 n=5 Participants	36.6 kg/m^2 n=7 Participants	37.0 kg/m^2 n=5 Participants
Primipara	108 Participants n=5 Participants	91 Participants n=7 Participants	199 Participants n=5 Participants
Hypertension Classification Chronic without Superimposed Preeclampsia	21 Participants n=5 Participants	23 Participants n=7 Participants	44 Participants n=5 Participants
Hypertension Classification Chronic with Superimposed Preeclampsia	22 Participants n=5 Participants	23 Participants n=7 Participants	45 Participants n=5 Participants
Hypertension Classification Gestational	62 Participants n=5 Participants	79 Participants n=7 Participants	141 Participants n=5 Participants
Hypertension Classification Preeclampsia	131 Participants n=5 Participants	112 Participants n=7 Participants	243 Participants n=5 Participants
Other Subtypes of Hypertension of Interest Mild Preeclampsia	51 Participants n=5 Participants	63 Participants n=7 Participants	114 Participants n=5 Participants
Other Subtypes of Hypertension of Interest Severe Preeclampsia	80 Participants n=5 Participants	49 Participants n=7 Participants	129 Participants n=5 Participants
Other Subtypes of Hypertension of Interest Hemolysis Elevated Liver enzyme Low Platelet (HELLP)	11 Participants n=5 Participants	1 Participants n=7 Participants	12 Participants n=5 Participants
Other Subtypes of Hypertension of Interest Eclampsia	1 Participants n=5 Participants	0 Participants n=7 Participants	1 Participants n=5 Participants
Married	163 Participants n=5 Participants	149 Participants n=7 Participants	312 Participants n=5 Participants
Tobacco Use	12 Participants n=5 Participants	21 Participants n=7 Participants	33 Participants n=5 Participants
Insurance Status Private	185 Participants n=5 Participants	157 Participants n=7 Participants	342 Participants n=5 Participants
Insurance Status Medicaid	29 Participants n=5 Participants	57 Participants n=7 Participants	86 Participants n=5 Participants
Pre-gestational Diabetes Mellitus	10 Participants n=5 Participants	13 Participants n=7 Participants	23 Participants n=5 Participants
Gestational age at delivery Preterm (less than 37 weeks)	57 Participants n=5 Participants	42 Participants n=7 Participants	99 Participants n=5 Participants
Gestational age at delivery Term (greater than or equal to 37 weeks)	157 Participants n=5 Participants	172 Participants n=7 Participants	329 Participants n=5 Participants

PRIMARY outcome

Timeframe: up to 3 months

Population: Aim 1 was an initial feasibility study enrolling 55 participants into the intervention.

A goal of 55 participants enrolled into the mobile health program was set as a feasibility target.

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=55 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aim 1: Number of Participants Enrolled	55 Participants	—

PRIMARY outcome

Timeframe: up to 6 weeks

Population: Aim 1 was an initial feasibility study enrolling 55 participants into the intervention.

To assess retention, the number of participants who completed the study will be reported.

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=55 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aim 1: Number of Participants Who Completed the Study	52 Participants	—

PRIMARY outcome

Timeframe: up to 1 year

Aims 2-5 primary endpoint is enrollment of up to 40 participants at all times (for a total of 42 days) over one year (220 experimental and 220 matched controls for chart review).

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aims 2-5: Number of Participants Enrolled in 1 Year	214 Participants	214 Participants

PRIMARY outcome

Timeframe: up to 6 weeks postpartum

Comparison of hypertension-related hospital readmissions between home telehealth with remote BP monitoring group and standard outpatient care during the first 6 weeks postpartum in women with hypertensive disorders of pregnancy (HDP).

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aims 2-5: Number of Participants With Hypertension-Related Hospital Readmissions	1 Participants	8 Participants

SECONDARY outcome

Timeframe: up to 6 weeks

Population: Aim 1 was an initial feasibility study enrolling 55 participants into the intervention.

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=55 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aim 1: 6-week Hospital Readmission	0 Participants	—

SECONDARY outcome

Timeframe: up to 6 weeks

Population: Aim 1 was an initial feasibility study enrolling 55 participants into the intervention.

Defined using American College of Obstetricians and Gynecologists (ACOG) criteria blood pressure values of ≥160mmHg (systolic) or ≥110 mmHg (diastolic)

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=55 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aim 1: Number of Participants With Severe Postpartum Hypertension After Discharge	9 Participants	—

SECONDARY outcome

Timeframe: up to 6 weeks postpartum

Population: Aim 1 was an initial feasibility study enrolling 55 participants into the intervention.

Comparison of hypertension-related emergency room visits between home telehealth with remote BP monitoring group and standard outpatient care during the first 6 weeks postpartum in women with HDP (hypertensive disorders of pregnancy).

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=55 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aim 1: Number of Participants With Hypertension-Related Emergency Room Visits	6 Participants	—

SECONDARY outcome

Timeframe: up to 6 weeks

Population: Aim 1 was an initial feasibility study enrolling 55 participants into the intervention.

Defined as participants having blood pressures exceeding the ACOG recommendations for blood pressure treatment (150/100 mmHg).

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=55 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aim 1: Number of Participants With Need for Blood Pressure Treatment After Discharge	29 Participants	—

SECONDARY outcome

Timeframe: up to 6 weeks postpartum

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aims 2-5: Number of Participants With Hypertension-Related Emergency Room Visits	10 Participants	13 Participants

SECONDARY outcome

Timeframe: up to 10 days of delivery

Comparison of number of participants with at least one blood pressure review within 10 days of delivery between home telehealth with remote BP monitoring group and standard outpatient care during the first 6 weeks postpartum in women with HDP (hypertensive disorders of pregnancy).

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aims 2-5: Number of Participants With at Least One Blood Pressure Review Within 10 Days of Delivery	202 Participants	129 Participants

SECONDARY outcome

Timeframe: up to 6 weeks postpartum

Comparison of number of participants on antihypertensive treatments between home telehealth with remote BP monitoring group and standard outpatient care during the first 6 weeks postpartum in women with HDP (hypertensive disorders of pregnancy).

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aims 2-5: Number of Participants on Antihypertensive Treatment Regimes	57 Participants	37 Participants

SECONDARY outcome

Timeframe: Admission to delivery (up to 96 hours)

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aims 2-5: Maximum Systolic Blood Pressure Intrapartum	160 mmHg Interval 152.0 to 171.0	158 mmHg Interval 151.0 to 167.0

SECONDARY outcome

Timeframe: Admission to delivery (up to 96 hours)

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aims 2-5: Maximum Diastolic Blood Pressure Intrapartum	101 mmHg Interval 96.0 to 110.0	102 mmHg Interval 96.0 to 109.0

SECONDARY outcome

Timeframe: Up to 96 hours postpartum

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aims 2-5: Systolic Blood Pressure at Discharge	131 mmHg Interval 124.0 to 138.0	129 mmHg Interval 121.0 to 136.0

SECONDARY outcome

Timeframe: Up to 96 hours postpartum

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aims 2-5: Diastolic Blood Pressure at Discharge	78 mmHg Interval 72.0 to 84.0	78 mmHg Interval 71.0 to 84.0

SECONDARY outcome

Timeframe: up to 96 hours postpartum

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aims 2-5: Medication at Discharge Any Antihypertensive	109 Participants	72 Participants
Aims 2-5: Medication at Discharge Labetalol	90 Participants	61 Participants
Aims 2-5: Medication at Discharge Nifedipine	39 Participants	20 Participants

SECONDARY outcome

Timeframe: up to 4.5 days

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aims 2-5: Postpartum Day of Discharge	3.35 days Standard Deviation 1.2	2.92 days Standard Deviation 1.1

SECONDARY outcome

Timeframe: up to 4 days post-partum

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aims 2-5: Inpatient Nonsteroidal Anti-inflammatory Drug (NSAID) Use	186 Participants	189 Participants

SECONDARY outcome

Timeframe: first prenatal care visit (on average 8-14 weeks of pregnancy, delivery (on average 37-40 weeks of pregnancy)

Population: Number of participants for which both first prenatal care weight and delivery weight were measured.

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=212 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=210 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Aims 2-5: Change in Weight From First Prenatal Care Visit to Delivery	14.6 kilograms Standard Deviation 8.0	14.4 kilograms Standard Deviation 8.4

SECONDARY outcome

Timeframe: up to 6 weeks postpartum

Population: Of the 214 participants enrolled in the intervention, 128 participants responded to the 6 week postpartum survey. Not all questions were answered by all survey respondents.

In collaboration with the University of Wisconsin Survey Center, the investigators developed a 37-question self-administered questionnaire (SAQ) satisfaction survey to all participants at the 6-week postpartum clinic visit. The survey utilized a variety of question formats including Likert scales with response ranging from 1 to 5 ("Not at all"; "A little"; "Somewhat"; "Quite a bit"; "A great deal" or "Never"; "Rarely"; "Sometimes"; "Very often"; "Extremely often"), dichotomous questions with a Yes/No response, and free text. A summary of mean scores (1-5) are reported here.

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=128 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Self-Administered Questionnaire Satisfaction Survey Scores How easy was it to get help?	3.33 score on a scale Standard Deviation 0.87	—
Self-Administered Questionnaire Satisfaction Survey Scores How satisfied are you with the mHealth devices?	3.32 score on a scale Standard Deviation 0.83	—
Self-Administered Questionnaire Satisfaction Survey Scores To what extent does using the mHealth tech make you feel safer?	2.86 score on a scale Standard Deviation 0.96	—
Self-Administered Questionnaire Satisfaction Survey Scores How secure do you feel submitting your vitals?	3.41 score on a scale Standard Deviation 0.76	—
Self-Administered Questionnaire Satisfaction Survey Scores How much more in control of your own health do you feel?	2.91 score on a scale Standard Deviation 0.9	—
Self-Administered Questionnaire Satisfaction Survey Scores How much more aware of your own health do you feel?	3.30 score on a scale Standard Deviation 0.74	—
Self-Administered Questionnaire Satisfaction Survey Scores Do you prefer going to clinic/hospital instead of using mHealth for postpartum follow-up?	0.31 score on a scale Standard Deviation 0.78	—
Self-Administered Questionnaire Satisfaction Survey Scores How much would you recommend mHealth to others in your situation?	3.49 score on a scale Standard Deviation 0.79	—
Self-Administered Questionnaire Satisfaction Survey Scores How enjoyable are the mHealth devices to use?	2.41 score on a scale Standard Deviation 1.06	—
Self-Administered Questionnaire Satisfaction Survey Scores How complicated are mHealth's instructions?	0.25 score on a scale Standard Deviation 0.67	—
Self-Administered Questionnaire Satisfaction Survey Scores How much mental effort does mHealth require?	0.59 score on a scale Standard Deviation 0.74	—
Self-Administered Questionnaire Satisfaction Survey Scores How easily does mHealth fit into your lifestyle?	2.65 score on a scale Standard Deviation 0.96	—
Self-Administered Questionnaire Satisfaction Survey Scores How confident do you feel using the mHealth devices?	3.46 score on a scale Standard Deviation 0.79	—
Self-Administered Questionnaire Satisfaction Survey Scores How hard is the monitor to use?	0.16 score on a scale Standard Deviation 0.49	—
Self-Administered Questionnaire Satisfaction Survey Scores How organized is the monitor?	3.27 score on a scale Standard Deviation 0.78	—
Self-Administered Questionnaire Satisfaction Survey Scores How helpful are the monitor's prompts?	2.57 score on a scale Standard Deviation 1.34	—
Self-Administered Questionnaire Satisfaction Survey Scores How easy is the blood pressure cuff to use?	3.44 score on a scale Standard Deviation 0.79	—
Self-Administered Questionnaire Satisfaction Survey Scores How hard is the weight scale to use?	0.37 score on a scale Standard Deviation 1.06	—
Self-Administered Questionnaire Satisfaction Survey Scores How reasonable is the amount of time it takes to record your blood pressure?	3.46 score on a scale Standard Deviation 0.77	—
Self-Administered Questionnaire Satisfaction Survey Scores How reasonable is the amount of time it takes to record your weight?	3.47 score on a scale Standard Deviation 0.79	—
Self-Administered Questionnaire Satisfaction Survey Scores How burdensome is it to record your blood pressure daily?	0.85 score on a scale Standard Deviation 0.93	—
Self-Administered Questionnaire Satisfaction Survey Scores How burdensome is it to record your weight daily?	0.78 score on a scale Standard Deviation 0.98	—
Self-Administered Questionnaire Satisfaction Survey Scores How often do you feel unsafe while using mHealth?	0.38 score on a scale Standard Deviation 1.06	—
Self-Administered Questionnaire Satisfaction Survey Scores How fun is answering questions using the Genesis Touch Monitor?	2.24 score on a scale Standard Deviation 1.03	—
Self-Administered Questionnaire Satisfaction Survey Scores Did the Genesis Touch Monitor have all functions you expected?	3.02 score on a scale Standard Deviation 0.98	—
Self-Administered Questionnaire Satisfaction Survey Scores Do you like the touch screen technology on the Genesis Touch monitor?	3.43 score on a scale Standard Deviation 0.74	—
Self-Administered Questionnaire Satisfaction Survey Scores Does using mHealth make you worry more, less or the same?	1.23 score on a scale Standard Deviation 0.63	—

SECONDARY outcome

Timeframe: up to 6 weeks postpartum

Population: Of the 214 participants enrolled in the intervention, 128 participants responded to the 6 week postpartum survey. Not all questions were answered by all survey respondents.

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=128 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Participant Counts for Relevant SAQ Satisfaction Survey Questions Number of Participants who had a hospital readmission	3 Participants	—
Participant Counts for Relevant SAQ Satisfaction Survey Questions Number of Participants who got help for problems with their devices	24 Participants	—
Participant Counts for Relevant SAQ Satisfaction Survey Questions Number of Participants for whom it took 1 minute to measure their blood pressure	118 Participants	—
Participant Counts for Relevant SAQ Satisfaction Survey Questions Number of Participants for whom it took 5 minutes to measure their blood pressure	11 Participants	—
Participant Counts for Relevant SAQ Satisfaction Survey Questions Number of Participants for whom it took 1 minute to measure their weight	122 Participants	—
Participant Counts for Relevant SAQ Satisfaction Survey Questions Number of Participants for whom it took 5 minutes to measure their weight	5 Participants	—
Participant Counts for Relevant SAQ Satisfaction Survey Questions Number of Participant who had any problems using the Genesis Touch monitor	49 Participants	—
Participant Counts for Relevant SAQ Satisfaction Survey Questions Number of Participants who had any problems using the blood pressure cuff	108 Participants	—
Participant Counts for Relevant SAQ Satisfaction Survey Questions Number of Participants who had any problems using the scale	107 Participants	—
Participant Counts for Relevant SAQ Satisfaction Survey Questions Number of Participants who had concerns sending their vitals to their health care provider	4 Participants	—
Participant Counts for Relevant SAQ Satisfaction Survey Questions Number of Participants who had enough control over their data	113 Participants	—
Participant Counts for Relevant SAQ Satisfaction Survey Questions Number of Participant who had to go to an emergency room after discharge	14 Participants	—
Participant Counts for Relevant SAQ Satisfaction Survey Questions Number of Participants who went to a different hospital than their delivery hospital	1 Participants	—

OTHER_PRE_SPECIFIED outcome

Timeframe: Up to 12 months

Cost effectiveness modeling will be performed to determine whether it is cost effective to use remote patient modeling for women with postpartum hypertension in comparison to standard outpatient care in women with hypertension-related disorders of pregnancy.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: at delivery (on average 37-40 weeks of pregnancy)

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Mode of Delivery Vaginal spontaneous	84 Participants	112 Participants
Mode of Delivery Cesarean	114 Participants	87 Participants
Mode of Delivery Operative vaginal	16 Participants	15 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: at time of birth

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Neonatal Birthweight	3180 grams Interval 2660.0 to 3540.0	3060 grams Interval 2610.0 to 3490.0

OTHER_PRE_SPECIFIED outcome

Timeframe: at birth

Outcome measures

Outcome measures
Measure	Mobile Health Participants n=214 Participants Participants will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.	Standard of Care n=214 Participants This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.
Neonatal Intensive Care Unit Admissions	67 Participants	55 Participants

Adverse Events

Mobile Health Participants

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Standard of Care

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Kara Hoppe, DO

University of Wisconsin School of Medicine and Public Health

Phone: (206) 371-4014

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place